Showing 6,701 - 6,720 results of 103,572 for search '(( 5 ((we decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (mean decrease)) ))', query time: 1.02s Refine Results
  1. 6701
  2. 6702
  3. 6703
  4. 6704

    Twenty-two identified and replicated loci and their overlap with associations to metabolic traits and clinical phenotypes. by Johannes Raffler (793347)

    Published 2015
    “…<p><sup>a</sup> SNP with the strongest association to targeted metabolic traits (“lead SNP”)</p><p><sup>b</sup> SNP with the strongest association to non-targeted metabolic traits</p><p><sup>c</sup> manually added to the list of most plausible candidate genes derived by evidence-based selection</p><p><sup>d</sup> additional candidates match to other non-targeted traits that also associate with the lead SNP</p><p><sup>e</sup> results from GWAS (<i>P</i> < 5.0×10<sup>−8</sup>)</p><p><sup>f</sup> mutations determined in clinical studies</p><p>For each locus, we selected all variants that displayed genome-wide significant association signals to metabolic traits in the SHIP-0 cohort. …”
  5. 6705

    Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates. by Alexandra Anderson (97972)

    Published 2013
    “…Treatment with 3.8 mg/ml 5-HT caused a 35% decrease in the number of Dar animals following <i>M. nematophilum</i> infection using standard assay conditions (small lawn) (A). …”
  6. 6706
  7. 6707

    PKRA7 decreases subcutaneous and intracranial glioblastoma xenograft tumor growth. by Valerie F. Curtis (276433)

    Published 2013
    “…<p>(<b>A</b>) D456MG cells were SC injected into nude mice, and control (n = 5) or PKRA7 (n = 5) treatment was commenced when tumors became visually detectable (14 days). …”
  8. 6708
  9. 6709
  10. 6710
  11. 6711
  12. 6712
  13. 6713
  14. 6714
  15. 6715
  16. 6716
  17. 6717
  18. 6718
  19. 6719
  20. 6720

    Baseline characteristics. by Jerry Bradley (22120384)

    Published 2025
    “…Above 45 years of age, the hazard of cancer incidence further decreased with advancing age.</p><p>Conclusions</p><p>Patients who were diagnosed with COVID-19 in the first wave of the pandemic had a decreased risk of cancer incidence in a 3-year follow-up across gender and race. …”